Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (5219)
SOPHiA GENETICS SA (SOPH)
Camblong Jurgi — Director
Shares
1,950
Price
$4.74
Total Value
$9.24K
Shares Held After
3,724,200
% of Holdings
0.1%
Monte Rosa Therapeutics, Inc. (GLUE)
Nickson Philip — Chief Business & Legal Officer
Shares
5,845
Price
$17.69
Total Value
$103.41K
Shares Held After
55,000
% of Holdings
9.6%
EXOZYMES INC. (EXOZ)
Korman Tyler Paz — Chief Scientific Officer
Shares
750
Price
$10.53
Total Value
$7.89K
Shares Held After
729,123
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
38
Price
$581.45
Total Value
$22.10K
Shares Held After
40,513
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,482
Price
$580.84
Total Value
$860.81K
Shares Held After
40,551
% of Holdings
3.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,046
Price
$580.07
Total Value
$606.75K
Shares Held After
42,033
% of Holdings
2.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,140
Price
$578.83
Total Value
$659.86K
Shares Held After
43,079
% of Holdings
2.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,815
Price
$577.90
Total Value
$1.05M
Shares Held After
44,219
% of Holdings
3.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,478
Price
$576.69
Total Value
$852.35K
Shares Held After
46,034
% of Holdings
3.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,241
Price
$575.75
Total Value
$714.51K
Shares Held After
47,512
% of Holdings
2.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,260
Price
$575.04
Total Value
$724.54K
Shares Held After
48,753
% of Holdings
2.5%
SOPHiA GENETICS SA (SOPH)
Muken Ross — President
Shares
1,950
Price
$4.74
Total Value
$9.24K
Shares Held After
693,361
% of Holdings
0.3%
SOPHiA GENETICS SA (SOPH)
Van Well Daan — Chief Legal Officer
Shares
1,988
Price
$4.74
Total Value
$9.42K
Shares Held After
348,820
% of Holdings
0.6%
SOPHiA GENETICS SA (SOPH)
Xu Zhenyu — Chief Scientific Officer
Shares
1,936
Price
$4.74
Total Value
$9.18K
Shares Held After
640,216
% of Holdings
0.3%
SOPHiA GENETICS SA (SOPH)
Menu Philippe — Chief Medical Officer
Shares
1,931
Price
$4.74
Total Value
$9.15K
Shares Held After
276,721
% of Holdings
0.7%
Pharvaris N.V. (PHVS)
Modig Berndt — Director
Shares
200
Price
$28.41
Total Value
$5.68K
Shares Held After
142,084
% of Holdings
0.1%
Pharvaris N.V. (PHVS)
Modig Berndt — Director
Shares
23,133
Price
$27.74
Total Value
$641.60K
Shares Held After
142,284
% of Holdings
14.0%
Relay Therapeutics, Inc. (RLAY)
Catinazzo Thomas — Chief Financial Officer
Shares
1,800
Price
$15.00
Total Value
$27.00K
Shares Held After
213,867
% of Holdings
0.8%
Edwards Lifesciences Corp (EW)
Ullem Scott B. — CVP, Chief Financial Officer
Shares
8,324
Price
$79.79
Total Value
$664.14K
Shares Held After
39,699
% of Holdings
17.3%
Edwards Lifesciences Corp (EW)
Ullem Scott B. — CVP, Chief Financial Officer
Shares
4,676
Price
$80.50
Total Value
$376.40K
Shares Held After
48,023
% of Holdings
8.9%
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)
Heshmatpour Amir F — Director
Shares
5,000
Price
$5.19
Total Value
$25.95K
Shares Held After
3,032,000
% of Holdings
0.2%
Apogee Therapeutics, Inc. (APGE)
HENDERSON MICHAEL THOMAS — Director
Shares
200
Price
$85.00
Total Value
$17.00K
Shares Held After
1,132,987
% of Holdings
0.0%
Apogee Therapeutics, Inc. (APGE)
HENDERSON MICHAEL THOMAS — Director
Shares
2,000
Price
$83.26
Total Value
$166.52K
Shares Held After
1,133,187
% of Holdings
0.2%
Apogee Therapeutics, Inc. (APGE)
HENDERSON MICHAEL THOMAS — Director
Shares
17,800
Price
$82.48
Total Value
$1.47M
Shares Held After
1,135,187
% of Holdings
1.5%
908 Devices Inc. (MASS)
McCallion Kevin J. — SVP, Products and Production
Shares
18,580
Price
$7.05
Total Value
$130.99K
Shares Held After
44,925
% of Holdings
29.3%
908 Devices Inc. (MASS)
Brown Christopher D. — Director
Shares
15,030
Price
$7.05
Total Value
$105.96K
Shares Held After
970,529
% of Holdings
1.5%
Adaptive Biotechnologies Corp (ADPT)
LO FRANCIS — Chief People Officer
Shares
22,564
Price
$15.07
Total Value
$340.04K
Shares Held After
271,154
% of Holdings
7.7%
Adaptive Biotechnologies Corp (ADPT)
ROBINS HARLAN S — Chief Scientific Officer
Shares
10,000
Price
$14.85
Total Value
$148.50K
Shares Held After
1,512,058
% of Holdings
0.7%
Vor Biopharma Inc. (VOR)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
130,862
Price
$16.91
Total Value
$2.21M
Shares Held After
4,071,637
% of Holdings
3.1%
Vor Biopharma Inc. (VOR)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
353,242
Price
$16.32
Total Value
$5.76M
Shares Held After
4,202,499
% of Holdings
7.8%
BeOne Medicines Ltd. (ONC)
Lee Chan Henry — SVP, General Counsel
Shares
332
Price
$311.59
Total Value
$103.45K
Shares Held After
0
% of Holdings
100.0%
Roivant Sciences Ltd. (ROIV)
Humes Jennifer — Chief Accounting Officer
Shares
13,538
Price
$28.37
Total Value
$384.07K
Shares Held After
84,191
% of Holdings
13.9%
Crinetics Pharmaceuticals, Inc. (CRNX)
Knight Jeff E. — Chief Dev. & Operating Officer
Shares
85,163
Price
$40.10
Total Value
$3.42M
Shares Held After
105,289
% of Holdings
44.7%
Ginkgo Bioworks Holdings, Inc. (DNA)
Canton Barry — 10% Owner
Shares
13,155
Price
$6.93
Total Value
$91.16K
Shares Held After
351,684
% of Holdings
3.6%
Ginkgo Bioworks Holdings, Inc. (DNA)
Kelly Jason R — Director
Shares
97,015
Price
$6.93
Total Value
$672.31K
Shares Held After
426,250
% of Holdings
18.5%
Ginkgo Bioworks Holdings, Inc. (DNA)
Shetty Reshma P. — Director
Shares
13,155
Price
$6.93
Total Value
$91.16K
Shares Held After
351,684
% of Holdings
3.6%
Immunovant, Inc. (IMVT)
Gloria Melanie — Chief Operating Officer
Shares
8,722
Price
$24.83
Total Value
$216.57K
Shares Held After
245,222
% of Holdings
3.4%
SOPHiA GENETICS SA (SOPH)
Camblong Jurgi — Director
Shares
2,800
Price
$4.84
Total Value
$13.55K
Shares Held After
3,726,150
% of Holdings
0.1%
Immunovant, Inc. (IMVT)
Van Tuyl Christopher — Chief Legal Officer
Shares
5,165
Price
$24.83
Total Value
$128.25K
Shares Held After
183,231
% of Holdings
2.7%
Omada Health, Inc. (OMDA)
Shao Wei-Li — President
Shares
2,829
Price
$12.71
Total Value
$35.95K
Shares Held After
328,850
% of Holdings
0.9%
EXOZYMES INC. (EXOZ)
Korman Tyler Paz — Chief Scientific Officer
Shares
750
Price
$10.04
Total Value
$7.53K
Shares Held After
729,873
% of Holdings
0.1%
Immunovant, Inc. (IMVT)
Stout Jay S — Chief Technology Officer
Shares
1,518
Price
$24.83
Total Value
$37.69K
Shares Held After
254,439
% of Holdings
0.6%
SOPHiA GENETICS SA (SOPH)
Valente Manuela — Chief People Officer
Shares
3,824
Price
$4.85
Total Value
$18.54K
Shares Held After
215,451
% of Holdings
1.7%
Immunovant, Inc. (IMVT)
Stout Jay S — Chief Technology Officer
Shares
8,614
Price
$24.83
Total Value
$213.89K
Shares Held After
255,957
% of Holdings
3.3%
SOPHiA GENETICS SA (SOPH)
Muken Ross — President
Shares
2,786
Price
$4.84
Total Value
$13.49K
Shares Held After
695,311
% of Holdings
0.4%
SOPHiA GENETICS SA (SOPH)
Van Well Daan — Chief Legal Officer
Shares
2,861
Price
$4.85
Total Value
$13.86K
Shares Held After
350,808
% of Holdings
0.8%
SOPHiA GENETICS SA (SOPH)
CARDOZA GEORGE — Chief Financial Officer
Shares
1,403
Price
$4.85
Total Value
$6.80K
Shares Held After
291,458
% of Holdings
0.5%
SOPHiA GENETICS SA (SOPH)
Xu Zhenyu — Chief Scientific Officer
Shares
2,800
Price
$4.84
Total Value
$13.55K
Shares Held After
642,152
% of Holdings
0.4%
SOPHiA GENETICS SA (SOPH)
Menu Philippe — Chief Medical Officer
Shares
2,800
Price
$4.84
Total Value
$13.54K
Shares Held After
278,652
% of Holdings
1.0%
DAXOR CORP (DXR)
Feldschuh Michael Richard — Director
Shares
1,000
Price
$9.07
Total Value
$9.07K
Shares Held After
213,694
% of Holdings
0.5%
Showing 501–550 of 5219 transactions (page 11 of 105)